ArticleJournal of ovarian research2026

Low muscle mass predicts poor response to neoadjuvant chemotherapy in advanced ovarian cancer.

Derya Demirtaş Esmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.